NK:IO
Pre-clinicalBy harnessing the potential of the innate immune system, we are developing ground breaking NK cell and small molecule therapies. Learn More at NK:IO.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $10M
About
By harnessing the potential of the innate immune system, we are developing ground breaking NK cell and small molecule therapies. Learn More at NK:IO.
Cell & Gene Therapy
Funding History
1Total raised:$10M
Seed$10MJun 15, 2022